Project Grant HT94252310969
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$551K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
This federal Project Grant award from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) provides $1,574,999.00 to The Ohio State University to conduct research on "SLIT2 as a novel approach for targeting metastatic breast cancer." The award, which runs from June 15, 2025 to June 14, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members and the broader public. The research at The Ohio State...
The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
This $472,498 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at The Ohio State University to target the UPP1-mediated pyrimidine salvage pathway to prevent ovarian cancer recurrence. The research aims to develop innovative approaches to disease prevention, diagnosis, and treatment for conditions relevant to military personnel and the broader public. This 2-year project,...
The Ohio State University received a $156,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The two-year award beginning in June 2021 will support research on Fatty Acid Binding Protein-5 as a novel therapeutic target against aggressive lung cancer. Through this funding, The Ohio State University researchers will investigate medical solutions for lung cancer, advancing the Military Medical Research...
The U.S. Department of the Army Medical Command awarded a $1,317,976 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Ohio State University. The grant titled "TARGETING THE RAL G PROTEINS TO TREAT TRIPLE-NEGATIVE BREAST CANCER" will fund advanced biomedical research to transform healthcare for military service members and the broader public. The 3-year project, running from July 1, 2025 to June 30, 2028, aims to conduct basic, applied,...
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
This federal Project Grant award of $1,251,451 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) aims to support research on metastatic progression in medullary thyroid cancer. The award period runs from July 1, 2023 to June 30, 2027 and will be carried out by the prime awardee, The Ohio State University (OSU). Under the grant, OSU will conduct genomic sequencing studies and organoid/metastasis-on-a-chip studies to investigate...
This Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on fusion-driven pediatric rhabdomyosarcomas at the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The research, spanning from September 1, 2025 to August 31, 2027, aims to conduct comprehensive in vivo phenotyping to transform healthcare for military service members and the broader...